Skip to content

Eccentric Exercise and Oxidative Stress

The Effect of Eccentric Exercise on Oxidative Stress in the Elderly

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01728675
Enrollment
20
Registered
2012-11-20
Start date
2012-05-31
Completion date
2012-07-31
Last updated
2012-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Muscle Damage, Oxidative Stress

Keywords

Aging, Skeletal muscle, Biomarkers, Adaptation

Brief summary

The purpose of the present investigation is to compare the responses and adaptations of young and elderly individuals to repeated eccentric exercise in regards to muscle function and redox homeostasis in a side-by-side comparison.

Detailed description

Despite the progress of analytic techniques and the refinement of study designs, striking disagreement exists among studies regarding the influence of exercise on muscle function and redox homeostasis in the elderly. A specific exercise protocol will be applied (the repeated eccentric model) to produce long-lasting and extensive changes in redox biomarkers and to examine more easily the potential effects of aging. Ten young men and ten elderly men will underwent an isokinetic eccentric exercise session, which will be repeated after three weeks. Muscle function indices and redox biomarkers will be assessed in urine, plasma or erythrocytes pre exercise, immediately post exercise, 2 and 4 days post exercise.

Interventions

OTHERExercise

Participants will perform two isokinetic eccentric exercise bouts

Sponsors

Aristotle University Of Thessaloniki
CollaboratorOTHER
European University Cyprus
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* subject provides written informed consent * physiological health profile * stable at their anthropometric characteristics for at least the last year

Exclusion criteria

* muscle disease * prior history of musculoskeletal injury to the lower limbs * smokers * consumed any nutritional supplement the last 3 months * performed intense eccentric exercise the last 6 months * non Caucasian

Design outcomes

Primary

MeasureTime frame
Muscle torque (torque)Change in muscle torque from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Range of motion, ROM (degrees)Change in ROM from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Delayed onset muscle soreness, DOMS (scale 1-10)Change in DOMS from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Creatine kinase, CK (activity IU)Change in CK from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise

Secondary

MeasureTime frame
Superoxide dismutase, SOD (U/g Hb)Change in SOD from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Glutathione peroxidase, GPx (U/g Hb)Change in GPx from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Glucose-6-phosphate dehydrogenase, G6PD (U/g Hb)Change in G6PD from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
F2-isoprostanes (pg/mg creatinine)Change in F2-isoprostanes from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Albumin (μM)Change in albumin from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Bilirubin (μM)Change in bilirubin from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Uric acid (mM)Change in uric acid from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Protein carbonyls (nmol/mg protein)Change in F2-isoprostanes from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Glutathione, GSH (μmol/g Hb)Change in GSH from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise
Catalase (U/g Hb)Change in catalase from baseline (pre-exercise) at immediately after exercise and at day 2 and day 4 post-exercise

Countries

Cyprus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026